Back

Catheter ablation in atrial fibrillation with concomitant mitral regurgitation: insights from the CABANA trial

19 May 2025 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Valve disease and heart failure - recognising opportunities Mitral Valve Regurgitation HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sebastiaan Dhont

Hospital Oost-Limburg (ZOL), Genk (Belgium)

3 More presentations in this session

Presentation thumbnail
Mitral valve prolapse: arrhythmic risk and prognosis
Doctor M. Dias (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Right ventricular-arterial coupling measured by cardiac magnetic resonance associates with outcomes: insights from a large cohort of patients with tricuspid regurgitation
Doctor D. Margonato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Development of tricuspid regurgitation after left-side heart surgery
Doctor M. Dias (Braga, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valve disease and heart failure - recognising opportunities

The Event

Event poster

Heart Failure 2025

19 May 2025 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation treatment paradigm in patients with mitral regurgitation
thumbnail
Congress Presentation
Mitral regurgitation decreases over time after successful thoracoscopic ablation, a subanalysis of a prospective cohort study.
thumbnail
Congress Session
Mitral regurgitation in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources